Thrivent Financial for Lutherans Has $59.43 Million Stock Holdings in Ingevity Co. (NYSE:NGVT)

Thrivent Financial for Lutherans lifted its position in Ingevity Co. (NYSE:NGVT - Free Report) by 2.7% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,359,556 shares of the company's stock after buying an additional 35,620 shares during the period. Thrivent Financial for Lutherans owned approximately 3.74% of Ingevity worth $59,427,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of NGVT. Wellington Management Group LLP boosted its holdings in Ingevity by 3.9% during the fourth quarter. Wellington Management Group LLP now owns 2,148,379 shares of the company's stock worth $101,446,000 after buying an additional 80,856 shares in the last quarter. UniSuper Management Pty Ltd acquired a new stake in shares of Ingevity during the 1st quarter valued at $522,000. Vanguard Group Inc. boosted its stake in shares of Ingevity by 4.3% during the 4th quarter. Vanguard Group Inc. now owns 3,743,322 shares of the company's stock worth $176,760,000 after acquiring an additional 153,530 shares in the last quarter. Swedbank AB acquired a new position in shares of Ingevity in the 1st quarter worth $3,372,000. Finally, Hsbc Holdings PLC raised its position in shares of Ingevity by 282.1% during the fourth quarter. Hsbc Holdings PLC now owns 33,084 shares of the company's stock worth $1,566,000 after purchasing an additional 24,426 shares during the period. Institutional investors and hedge funds own 91.59% of the company's stock.

Ingevity Trading Down 3.0 %

NYSE:NGVT opened at $40.04 on Friday. The stock's 50-day moving average is $39.40 and its two-hundred day moving average is $44.49. The company has a debt-to-equity ratio of 4.92, a current ratio of 1.92 and a quick ratio of 1.07. The stock has a market cap of $1.45 billion, a PE ratio of -12.87 and a beta of 1.62. Ingevity Co. has a fifty-two week low of $32.21 and a fifty-two week high of $56.29.

Ingevity (NYSE:NGVT - Get Free Report) last announced its quarterly earnings data on Wednesday, July 31st. The company reported $1.01 EPS for the quarter, missing analysts' consensus estimates of $1.05 by ($0.04). The company had revenue of $390.60 million for the quarter, compared to analysts' expectations of $407.58 million. Ingevity had a negative net margin of 27.85% and a positive return on equity of 19.59%. The business's revenue for the quarter was down 18.9% on a year-over-year basis. During the same period in the previous year, the firm posted $1.41 earnings per share. As a group, equities research analysts forecast that Ingevity Co. will post 2.63 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

NGVT has been the subject of a number of recent analyst reports. BMO Capital Markets decreased their price target on Ingevity from $45.00 to $42.00 and set a "market perform" rating for the company in a research report on Monday, August 5th. CJS Securities upgraded shares of Ingevity from a "market perform" rating to an "outperform" rating and set a $58.00 target price for the company in a report on Wednesday, August 7th. Wells Fargo & Company dropped their target price on shares of Ingevity from $45.00 to $40.00 and set an "equal weight" rating on the stock in a research report on Monday, August 5th. Finally, Oppenheimer reduced their price target on shares of Ingevity from $58.00 to $50.00 and set an "outperform" rating for the company in a research report on Thursday, August 1st. Four analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $51.33.

Ingevity Company Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.